Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - Commentary.
Impact of Minocycline on Extracellular Matrix Metalloproteinase Inducer, a Factor Implicated in Multiple Sclerosis Immunopathogenesis.
Accelerated generation of oligodendrocyte progenitor cells from human induced pluripotent stem cells by forced expression of Sox10 and Olig2.
Incidence and Natural History of Idiopathic Chronic Inflammatory Demyelinating Polyneuropathy: A Population-Based Study in Iceland.
Meeting the mental health needs of people with multiple sclerosis: a qualitative study of patients and professionals.
CIDP presenting as recurrent severe back pain without weakness or sensory loss.
Dysautonomic polyneuropathy as a variant of chronic inflammatory "demyelinating" polyneuropathy?
T cell cytokine signatures: Biomarkers in pediatric multiple sclerosis.
Contraceptive use among women with multiple sclerosis: a systematic review.
The influence of coping styles on long-term employment in multiple sclerosis: A prospective study.
Stress Urinary Incontinence in Women With Multiple Sclerosis.
Chaperome screening leads to identification of Grp94/Gp96 and FKBP4/52 as modulators of the α-synuclein-elicited immune response.
Spasticity in multiple sclerosis and role of glatiramer acetate treatment.
Autoantibody-mediated encephalitis: Not just paraneoplastic, not just limbic, and not untreatable.
N98S mutation in NEFL gene is dominantly inherited with a phenotype of polyneuropathy and cerebellar atrophy.
Discovery and Structure-Activity Relationship (SAR) of a Series of Ethanolamine-Based Direct-Acting Agonists of Sphingosine-1-phosphate (S1P1).
High Intensity Aerobic and Resistance Exercise Can Improve Glucose Tolerance in Persons With Multiple Sclerosis: A Randomized Controlled Trial.
Determinants of stigma in a cohort of hellenic patients suffering from multiple sclerosis: a cross-sectional study.
The ER membrane-anchored ubiquitin ligase Hrd1 is a positive regulator of T-cell immunity.
Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS).
Microbiomic and Posttranslational Modifications as Preludes to Autoimmune Diseases.
Thalamus Degeneration and Inflammation in Two Distinct Multiple Sclerosis Animal Models.
Silver nanoparticles exhibit size-dependent differential toxicity and induce expression of syncytin-1 in FA-AML1 and MOLT-4 leukaemia cell lines.
Regarding the past, what is the trial you have always been dreaming of in CIDP?
Quantifying Beta-Galactosylceramide Kinetics in Cerebrospinal Fluid of Healthy Subjects Using Deuterium Labeling.

Pages